Berberine improves insulin resistance through mechanisms related to regulating the PPM1B signaling pathway, including the cAMP/PKA/PPM1B, PPM1B/GLUT4, PPM1B/IKKβ/NF-κB, and PPM1B/PI3K/AKT pathways. Here, SLC2A4 is linked to Insulin resistance.